Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA01 - Oligometastatic Disease
- 10:30 - 12:00
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Oligometastatic NSCLC
- Moderators:Anne Marie Clasina Dingemans, Matthias Guckenberger
-
+
MA01.09 - Concomitant SBRT and EGFR-TKI Versus EGFR-TKI Alone for Oligometastatic NSCLC: A Multicenter, Randomized Phase II Study
11:30 - 11:35 | Presenter: Li Zhang | Author(s): Ping Peng, Yongshun Chen, Guang Han, Rui Meng, Sheng Zhang, Zhengkai Liao, Yujie Zhang, Juejun Gong, Chuangying Xiao, Xiyou Liu, Peng Zhang, Lu Zhang, Shu Xia, Qian Chu, Yuan Chen
- Abstract
Loading...
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- 13:30 - 15:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Christine Lee Hann, Makoto Nishio
-
+
OA03.02 - Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial
13:40 - 13:50 | Presenter: Qiming Wang | Author(s): Ying Cheng, Kai Li, Jianhua Shi, Baohui Han, Lin Wu, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiao-Ling Li
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-03 - Efficacy and Safety of Biosimilar QL1101 Compared with Avastin in Patients with Non-Squamous Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Baohui Han | Author(s): Kai Li, Tianqing Chu, Minghong Bi, Helong Zhang, Yan Yu, Jianhua Shi, Xiaochun Zhang, Zhendong Chen, Cuicui Han, Tao Bai
- Abstract
Loading...
-
+
P2.12 - Small Cell Lung Cancer/NET
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P2.12-11 - Quality of Life in ALTER1202 Trial of Anlotinib as Third-or Further Line Therapy for Advanced Small Cell Lung Cancer (SCLC): A Post-Hoc Analysis
10:15 - 10:15 | Presenter: Kai Li | Author(s): Ying Cheng, Qiming Wang, Jianhua Shi, Baohui Han, Lin Wu, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiaolin Li
- Abstract
Loading... -
+
P2.12-26 - The Impact of Anlotinib for Relapsed SCLC Patients with Brain Metastases: A Subgroup Analysis of ALTER 1202
10:15 - 10:15 | Presenter: Ying Cheng | Author(s): Qiming Wang, Kai Li, Jianhua Shi, Baohui Han, Lin Wu, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiao-Ling Li
- Abstract
Loading...
-
+
MA25 - Precision Medicine in Advanced NSCLC
- 14:30 - 16:00
- 9/10/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Sebastian Defranchi, Karen Kelly
-
+
MA25.09 - Navigating Anlotinib Precision Therapy Through the Genetic Profiling of Circulating DNA in Non-Small Cell Lung Cancer Patients
15:29 - 15:36 | Presenter: Jun Lu | Author(s): Hua Zhong, Jun Wu, Tianqing Chu, Lele Zhang, Hua Li, Qiming Wang, Rong Li, Yizhuo Zhao, Aiqin Gu, Chunlei Shi, Liwen Xiong, Xueyan Zhang, Wei Zhang, Yuqing Lou, Bo Yan, Yu Dong, Yanwei Zhang, Baolan Li, Li Zhang, Xiaodong Zhao, Kai Li, Baohui Han
- Abstract
Loading...